Physician profile
William Thomas Sorrell
NPI 1417031295
$235.16
in general payments reported to CMS, 2019-2025
11 companies · $63.96 in 2025
The $63.96 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.70 · 2020: $77.16 · 2021: $11.61 · 2022: $38.03 · 2024: $13.70 · 2025: $63.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $61.47 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.74 | 2025 | Eohilia |
| Abbott Laboratories | $25.39 | 2022 | |
| Stryker Corporation | $19.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2025 | |
| Leica Microsystems INC. | $15.69 | 2020 | |
| Fresenius USA Marketing, INC. | $14.73 | 2025 | Velphoro |
| Mallinckrodt Hospital Products INC. | $13.70 | 2024 | Acthar |
| Amgen INC. | $12.64 | 2022 | |
| Novo Nordisk INC | $11.61 | 2021 | |
| Lilly USA, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sorrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.